Fibroadenoma News and Research

RSS

A tumor in the breast represents the most common complaint for which women consult a physician, referring to their change as a mass or a thickening. Approximately 70% of all breast tumors are benign, while fibroadenomas are considered the second most common benign breast lesion with an incidence of 18-20% (following omnipresent fibrocystic changes in the breast).

Women with benign breast conditions can undergo surgery without affecting their ability to breastfeed

Young women with benign breast conditions may undergo surgery without jeopardizing their ability to breastfeed later on.

5 Oct 2020

Clinical study tests efficacy of new focused ultrasound-based treatment for breast fibroadenoma

Patients with benign breast tumors may be eligible for a new focused ultrasound-based investigational treatment as part of a pivotal, multi-center clinical study. The trial began last month at the University of Virginia Medical Center.

20 Mar 2017

Scientists identify culprit genes behind the formation and progression of breast tumours

A team from the SingHealth Duke-NUS Academic Medical Centre, comprising scientists and clinicians from the National Cancer Centre Singapore, Singapore General Hospital and Duke-NUS Graduate Medical School, has uncovered the genetic landscape of a distinct breast tumour group called fibroepithelial tumours.

8 Oct 2015

OHTAC recommends MRgHIFU as possible cost-effective strategy for uterine fibroid treatment

The Ontario Health Technology Advisory Committee has recommended Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU or MRgFUS) as a possible "cost-effective strategy" and a "safe and effective, noninvasive, uterine-preserving" option for women seeking treatment for uterine fibroids.

27 Apr 2015

Scientists make seminal breakthrough in understanding molecular basis of fibroadenoma

A multi-disciplinary team of scientists from the National Cancer Centre Singapore, Duke-NUS Graduate Medical School Singapore, and Singapore General Hospital have made a seminal breakthrough in understanding the molecular basis of fibroadenoma, one of the most common breast tumours diagnosed in women.

21 Jul 2014

Researchers use "big data" analytics to predict triple-negative breast cancer and other cancers with 95% accuracy

Researchers at Case Western Reserve University and colleagues used "big data" analytics to predict if a patient is suffering from aggressive triple-negative breast cancer, slower-moving cancers or non-cancerous lesions with 95 percent accuracy.

19 Mar 2014

Theraclion unveils very positive initial clinical results in treatment of thyroid nodules

Theraclion, a company specializing in advanced medical equipment for echotherapy (or ultrasound therapy), has unveiled very positive initial clinical results in the treatment of thyroid nodules. These findings demonstrate the effectiveness of its Echopulse device in the treatment of this condition.

10 Oct 2013

Raman spectroscopy algorithm has potential to diagnose breast lesions with high precision

A newly developed, single-step Raman spectroscopy algorithm has the potential to simultaneously detect microcalcifications and enable diagnosis of the associated breast lesions with high precision, according to data published in Cancer Research, a journal of the American Association for Cancer Research.

31 May 2013

New software improves accuracy of breast thermography in detection of cancer

Straightforward imaging with an infrared, thermal, camera for detecting breast cancer early without the discomfort or inconvenience of mammography or biomolecular tests, according to a study to be published in the International Journal of Innovative Computing and Applications.

15 Nov 2012

MRI method ‘cuts breast cancer false‑positives’

Assessing apparent diffusion coefficients during dynamic contrast-enhanced magnetic resonance imaging may reduce the number of avoidable false‑positive breast cancer results and unnecessary biopsies, show findings published in Radiology.

9 Oct 2012

Novian Health commences multicenter Novilase Interstitial Laser Therapy clinical trial for breast cancer

Novian Health, developer of Novilase Breast Therapy, announced the company has begun a multicenter clinical trial on the use of Novilase Interstitial Laser Therapy (ILT) for the destruction of malignant breast tumors.

12 Apr 2012

FDA grants Novian Health IDE approval for Novilase ILT System to treat breast cancer

Novian Health, developer of Novilase® Breast Therapy, announced that the US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval for the company to start a multi-center study of its Novilase® Interstitial Laser Therapy (ILT) System. Novian developed the ILT System for the ablation of small (up to 20 mm) malignant breast tumors.

14 Jul 2011

Nurse with enhanced clinical skills detects same breast abnormalities as surgeon

UK researchers have developed an Initiative that could help hospitals prevent delays to the two-week cancer target, following the reduction in junior doctors' working hours due to the European Working Time Directive. A specially trained nurse practitioner and consultant breast surgeon who examined 126 women referred to a symptomatic breast disease clinic picked up the same breast abnormalities in 92% of cases.

14 Jun 2010

Study finds groundbreaking technology in TechniScan's Warm Bath Ultrasound promising

TechniScan, Inc.'s unique whole breast ultrasound technology, which provides a comfortable, radiation-free method for assessment of breast lesions was part of a scientific presentation at the National Consortium of Breast Centers (NCBC) conference in Las Vegas last week.

31 Mar 2010

Occult lesions identified with BSGI can be localized using multi-modality imaging for needle biopsy

Dr. Jocelyn Rapelyea, Associate Director of Breast Imaging and Intervention at George Washington University Medical Center in Washington, D.C., demonstrated how occult lesions identified with Breast-Specific Gamma Imaging (BSGI) can be localized utilizing multi-modality imaging for needle biopsy as well, as for pre-operative localization today at the annual meeting of the Radiological Society of North America (RSNA).

2 Dec 2009

SuperSonic Imagine signs distribution agreement with Canon Marketing Japan

SuperSonic Imagine today announced that it has signed an exclusive distribution agreement with Canon Marketing Japan Inc. (Canon MJ) to develop the Japanese market.

1 Dec 2009

Short-term follow-up a reasonable alternative to biopsy of palpable breast lesions

Short-term follow-up is a reasonable alternative to invasive biopsy of palpable (capable of being touched or felt) breast lesions with benign imaging features, particularly in younger women with probable fibroadenoma (non-cancerous tumors that often occur in women during their reproductive years), according to a study published in the December issue of the American Journal of Roentgenology.

21 Nov 2009

Novian Health and Rose Medical Center sign an agreement to provide Novilase laser treatment to treat breast lumps

Novian Health, manufacturer of Novilase™ Breast Therapy for benign breast tumors, announced an agreement with Rose Medical Center for Rose to provide the Novilase laser treatment to treat breast lumps.

29 Oct 2009

Complex fibroadenomas patients can avoid surgery

Complex fibroadenomas have a low incidence of malignancy, so women with this condition can be more conservatively treated and avoid surgical biopsy, according to a new study by a team of researchers from the Hadassah-Hebrew University Medical Center in Jerusalem.

12 Feb 2008

Cryoablation preferred option for treatment of breast fibroadenoma

Sanarus Inc., a developer of minimally invasive diagnostic and treatment tools for breast disease, announced today that twelve-month follow-up data from a peer-reviewed, prospective multicenter study demonstrates that cryoablation is a preferred first-line treatment for breast fibroadenoma for women who do not want to undergo open surgery.

14 Sep 2004